Guided Therapeutics GTHP
OTC GTHP
$0.15 -0.01 (-6.25%)
At close: Oct 21, 2026 · 4:00 PM EDT

Guided Therapeutics (GTHP) Short-Term Debt issuances (2020 - 2022)

Updated

Guided Therapeutics (GTHP) reported Short-Term Debt issuances of -$90,000 for Q1 2022, compared with -$557,000 a year earlier.

Analysis

Guided Therapeutics (GTHP) Short-Term Debt issuances (2020 - 2022) Analysis & Trends

Over the twelve months ended Mar 31, 2022, Guided Therapeutics' Short-Term Debt issuances came in at -$842,000; for FY2021, it was -$1.47 million.

  • By year, Short-Term Debt issuances came in at -$1.1 million in FY2020.
  • Five-year quarterly Short-Term Debt issuances spans a low of -$557,000 in Q1 2021 and a high of -$53,000 in Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Thermo Fisher Scientific 250.71 Bn 229.74 Bn 4.88 Bn -
2 Abbott Laboratories 178.38 Bn 148.81 Bn 7.27 Bn -
3 Danaher 161.61 Bn 145.42 Bn 3.61 Bn -
4 Intuitive Surgical 154.15 Bn 134.44 Bn 2.08 Bn -
5 Medtronic 123.21 Bn 88.46 Bn 6.34 Bn -
6 Stryker 117.50 Bn 103.61 Bn 4.50 Bn -
7 Boston Scientific 67.50 Bn 62.26 Bn 3.85 Bn -
8 Becton Dickinson 54.80 Bn 51.95 Bn 2.32 Bn -
9 Edwards Lifesciences 51.78 Bn 35.79 Bn 1.35 Bn -
10 Guided Therapeutics 16.41 Mn 15.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -90,000.00
Dec 31, 2021 -53,000.00
Mar 31, 2021 -557,000.00
Dec 31, 2020 -142,000.00
API Access

Guided Therapeutics Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=GTHP&period=max&api_key=YOUR_API_KEY